- Filed
- Sep 11, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Sep 8, 2025 | 11.93M sh |
| Shares Diluted | FY 2024 · Dec 31, 2023 | 9.38M sh |
| Capex | FY 2024 · Dec 31, 2023 | $2.26M |
| Operating Cash Flow | FY 2024 · Dec 31, 2023 | $12.72M |
| Cash And Equivalents | FY 2024 · Dec 31, 2023 | $98.04M |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $6.34M |
| Total Liabilities | FY 2024 · Dec 31, 2023 | $6.72M |
| Current Assets | FY 2024 · Dec 31, 2023 | $106.78M |
| Total Assets | FY 2024 · Dec 31, 2023 | $119.64M |
| Eps Diluted | FY 2024 · Dec 31, 2023 | $0.89 |
| Eps Basic | FY 2024 · Dec 31, 2023 | $0.89 |
| Sga Expense | FY 2024 · Dec 31, 2023 | $3.85M |
| Rd Expense | FY 2024 · Dec 31, 2023 | $84.55K |
| Net Income | FY 2024 · Dec 31, 2023 | $8.26M |
| Operating Income | FY 2024 · Dec 31, 2023 | $12.65M |
| Gross Profit | FY 2024 · Dec 31, 2023 | $17.19M |
| Cost Of Revenue | FY 2024 · Dec 31, 2023 | $22.52M |
| Revenue restated | FY 2024 · Dec 31, 2023 | $12.04M |
| Stockholders Equity | FY 2024 · Dec 31, 2022 | $68.83M |